Upgrade to SI Premium - Free Trial

Kodiak Sciences Inc. (KOD)

92.95 -0.02 (0.02%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/12/26)

Latest Headlines

Kodiak Sciences Inc. (KOD) files mixed shelf October 20, 2026 5:27 PM - StreetInsider Form S-3ASR Kodiak Sciences Inc. October 20, 2026 5:19 PM - SEC Filing Kodiak Sciences Inc. (KOD) PT Raised to $126 at H.C. Wainwright October 12, 2026 6:50 AM - StreetInsider Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026 October 7, 2026 7:00 AM - PR NewsWire Form SCHEDULE 13D/A Kodiak Sciences Inc. Filed by: BAKER BROS. ADVISORS LP September 30, 2026 4:39 PM - SEC Filing Form 4 Kodiak Sciences Inc. For: Sep 28 Filed by: Baker Brothers Life Sciences LP September 30, 2026 4:31 PM - SEC Filing Form 4 Kodiak Sciences Inc. For: Sep 28 Filed by: Baker Brothers Life Sciences LP September 30, 2026 4:30 PM - SEC Filing Form 4 Kodiak Sciences Inc. For: Sep 28 Filed by: Baker Brothers Life Sciences LP September 30, 2026 4:29 PM - SEC Filing Form 4 Kodiak Sciences Inc. For: Sep 25 Filed by: PERLROTH VICTOR September 29, 2026 7:44 PM - SEC Filing Kodiak Sciences Inc. (KOD) PT Raised to $96 at H.C. Wainwright September 29, 2026 6:46 AM - StreetInsider Kodiak Sciences Inc. (KOD) PT Lowered to $112 at Jefferies September 28, 2026 1:32 PM - StreetInsider 4 Explosive Stories Enter the Investor Spotlight September 28, 2026 11:52 AM - StreetInsider Increasing unusual call option volume: KOD AMTX VET ITB MDB SOLZ ALGM DC PACS CM PLNT DASH AMPX September 28, 2026 10:14 AM - StreetInsider Increasing unusual option volume: TRGP KOD ADMA MTN AMTX WHR VET MDB CM SOLZ PRCT September 28, 2026 10:13 AM - StreetInsider Kodiak Sciences stock soars on positive AMD trial data September 28, 2026 9:15 AM - StreetInsider Form 8-K Kodiak Sciences Inc. For: Sep 28 September 28, 2026 8:54 AM - SEC Filing Kodiak Sciences drugs meet primary endpoints in wet AMD trial September 28, 2026 6:31 AM - StreetInsider Zenkuda and tabirafusp-ted Meet Primary Endpoints in Pivotal DAYBREAK Trial in wAMD, with Zenkuda Demonstrating a Potential New Standard-of-Care Profile with Strong Immediacy and Sustained Clinical Ef September 28, 2026 6:30 AM - PR NewsWire Kodiak Sciences to release Phase 3 wet AMD study results Sept. 28 September 25, 2026 6:02 PM - StreetInsider Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration September 25, 2026 6:02 PM - PR NewsWire Increasing unusual option volume: KOD BBD ABUS BHF NEOV SVRA IHI SGHC GXO September 25, 2026 6:06 AM - StreetInsider Goldman Sachs Assumes Kodiak Sciences Inc. (KOD) at Neutral September 24, 2026 5:00 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Kodiak Sciences Inc. (KOD) September 17, 2026 6:52 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Kodiak Sciences Inc. (KOD) August 17, 2026 6:43 AM - StreetInsider Form SCHEDULE 13G Kodiak Sciences Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/ August 14, 2026 10:39 AM - SEC Filing Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c August 13, 2026 4:39 PM - StreetInsider Form 10-Q Kodiak Sciences Inc. For: Jun 30 August 13, 2026 4:18 PM - SEC Filing Form 8-K Kodiak Sciences Inc. For: Aug 13 August 13, 2026 4:00 PM - SEC Filing Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results August 13, 2026 4:00 PM - PR NewsWire Kodiak Sciences enrolls first patients in Phase 3 DME trial August 10, 2026 4:44 PM - StreetInsider Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema August 10, 2026 4:43 PM - PR NewsWire Kodiak Sciences completes enrollment in Phase 3 PEAK trial cohort August 6, 2026 7:00 AM - StreetInsider Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Tra August 6, 2026 7:00 AM - PR NewsWire Kodiak Sciences Inc. (KOD) PT Raised to $66 at JPMorgan August 3, 2026 7:51 AM - StreetInsider Full Article List